ANTHRACYCLINE CARDIOTOXICITY IN NON-HODGKIN’S LYMPHOMA MEDIASTINAL MASS: A CASE REPORT

Anthracycline is often used for treatment of hematologic malignancies and solid tumors, and the damage it causes to the heart muscle has long been known; therefore, the cardiac toxicity, one of the treatment-related co-morbidities, has become an issue for cancer survivors. Cardiotoxicity has been...

Full description

Bibliographic Details
Main Author: Elisabetta Chiodi
Format: Article
Language:English
Published: Associazione Italiana Giovani Medici 2015-04-01
Series:Euromediterranean Biomedical Journal
Online Access:http://www.embj.org/images/ISSUE_2015/Natali_4.pdf